Acta dermato-venereologica
The Absence of Recent Systemic Therapy can be a Significant Risk Factor for Nemolizumab-associated Cutaneous Adverse Events in Patients with Prurigo Nodularis: A Single-centre Retrospective Study.
Yoshihito Mima, Masako Yamamoto, Ken Iozumi
Published: 202510.2340/actadv.v105.44310
No abstract available for this study.